Rosmarinic Acid for Health & Longevity - Quick Reference Sheet

Rosmarinic Acid for Health & Longevity

Created on 07/31/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Rosmarinic acid is a plant compound from cooking herbs, valued for calming inflammation and neutralizing the reactive molecules that wear cells down. Its strongest human use is easing seasonal allergy symptoms; standardized herbal extracts show modest effects on memory, joint stiffness, calmness, sleep, and fatigue. Well tolerated and low-cost, though bigger longevity claims rest largely on lab and animal work. (Full Review)

Protocol

Dose
50–200 mg/day
Rosmarinic acid, isolated or standardized extract
Frequency
2–3× daily with food
Split dosing suits the short half-life
Timing
By goal
Evening lemon balm for sleep; morning/midday for cognition
Time to effect
Allergy relief
Days–weeks
Standardized perilla extract
Anti-inflammatory
Weeks–months
Daily use
Cognition
~90 days
Spearmint extract

Benefits

Contraindications
  • Known mint-family (Lamiaceae) or perilla allergy
  • Pregnancy or breastfeeding
  • Bleeding disorders or surgery within ~2 weeks
Key Interactions
  • Anticoagulants/antiplatelets (warfarin, apixaban, clopidogrel, aspirin)
  • Antihypertensives (ACE inhibitors, ARBs, calcium-channel blockers)
  • Antidiabetics (metformin, sulfonylureas, insulin)
  • OTC NSAIDs (ibuprofen, naproxen) and aspirin
  • Blood-thinning/anti-inflammatory supplements (fish oil, ginkgo, garlic, vitamin E, curcumin)
  • Oxidative cancer therapies and exercise (antioxidant timing)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal discomfort; allergic & hypersensitivity reactions; increased bleeding tendency; additive blood-pressure lowering
  • Speculative: Pregnancy & uterine stimulation; blunting of pro-oxidant cancer therapies; high-dose pro-oxidant and fertility effects

Monitoring

Marker Target Why
hs-CRP < 1.0 mg/L Tracks the anti-inflammatory response
Blood pressure ~110–120 / 70–80 mmHg Detects additive lowering when co-medicated
Fasting glucose 75–90 mg/dL Screens for additive glucose lowering
HbA1c < 5.4% Longer-term glucose context
ALT / AST ALT < 25 U/L; AST < 25 U/L Reassurance given preclinical liver focus
Platelet count / bleeding signs 150–400 ×10⁹/L Relevant only with anticoagulant/antiplatelet co-use

Cadence: Re-check goal-specific markers at ~4–8 weeks, then every 6–12 months; more frequent blood-pressure, glucose, or bleeding checks if co-medicated

Qualitative Assessment

  • Allergy symptoms: frequency and intensity of nasal and eye symptoms
  • Joint comfort: morning stiffness and ease of movement
  • Cognitive clarity: focus, working memory, mental sharpness
  • Sleep and mood: sleep quality, calmness, stress reactivity
  • Energy and fatigue: day-to-day energy levels